Answer:

All patients should be monitored for temperature unless the patient or the situation makes such monitoring impractical or unobtainable. An example of such would be endoscopy or colonoscopy wherein such monitoring may be more stimulating that the procedure.

Reference # 5739109

Answer:

Observe the patient for several hours AFTER the patient is awake and demonstrating no other signs or symptoms of MH. Normal laboratory tests such as CPK, K+ are helpful as well. If uncertain, it is a good idea to admit the patient and observe over night when unsure.

Reference #  5120488

Answer:

No data exists on the effectiveness of any of the dantrolene products when administered via the intraosseous route. However, in the event that the patient is experiencing an acute MH event, and intravenous access can not be secured, it would be prudent to administer the dantrolene intraosseous in an attempt to get it into the patient to treat the MH episode.

Answer:

Cotton cloths covered with cold water and ice. Can also do gastric lavage, infusion of cold IV solution, etc

Question:

Dantrolene is hard to mix. We are currently using bags of bacteriostatic free sterile water to mix our dantrolene. It is difficult for us to spike the bag each time and draw it with our 18 gauge needles. What is the best syringe/device available to obtain the water from the bag to rapidly draw it out with a syringe to mix it with the dantrolene?

Answer:

You should use glass vials and not bags because of the possibility of accidentally giving intravenously. There are various spring-loaded syringes that may help with this process. The new dantrolene preparation Ryanodex requires only 5 mL per 250 mg vial.